Pfizer acquires antifungal therapies developer Amplyx
The acquisition follows Pfizer’s initial equity investment in Amplyx, as part of the antifungal therapies developer's Series C…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Apr 21
The acquisition follows Pfizer’s initial equity investment in Amplyx, as part of the antifungal therapies developer's Series C…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
28 Apr 21
Exscientia intends to use the funding to advance its pipeline through clinical testing along with expanding its technology…
28 Apr 21
The company is also committed to donating more than $5m in supplies and equipment to support the pandemic…
27 Apr 21
Sanofi to dedicate its site in Ridgefield, New Jersey to perform fill and finish operations for up to…
26 Apr 21
GSK claimed that its Jemperli is the first anti-PD-1 therapy approved for recurrent or advanced endometrial cancer
26 Apr 21
Use of J&J’s single-shot Covid-19 vaccine was paused after the vaccination induced a rare and severe thrombosis with…
23 Apr 21
The new facility will feature advanced technologies, the latest manufacturing equipment and advanced digital systems to deliver critical…
23 Apr 21
The FDA accelerated approval is based on the results from the dMMR endometrial cancer cohort of the ongoing…
22 Apr 21
J.POD 2 EU marks Evotec’s second cGMP biomanufacturing facility and will be the first commercial biomanufacturing facility in…
21 Apr 21
The PRAC recommendation enables J&J to resume the supply of its Covid-19 vaccine in the European Union (EU),…